KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $136.0 million.

  • Exact Sciences' Capital Expenditures rose 14.29% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.7 million, marking a year-over-year increase of 3.81%. This contributed to the annual value of $136.0 million for FY2024, which is 9.50% up from last year.
  • As of FY2024, Exact Sciences' Capital Expenditures stood at $136.0 million, which was up 9.50% from $124.2 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Capital Expenditures ranged from a high of $411.4 million in FY2020 and a low of $124.2 million during FY2023.
  • For the 3-year period, Exact Sciences' Capital Expenditures averaged around $158.2 million, with its median value being $136.0 million (2024).
  • Per our database at Business Quant, Exact Sciences' Capital Expenditures soared by 138.29% in 2020 and then tumbled by 67.00% in 2021.
  • Yearly analysis of 5 years shows Exact Sciences' Capital Expenditures stood at $411.4 million in 2020, then plummeted by 67.00% to $135.8 million in 2021, then surged by 57.96% to $214.5 million in 2022, then plummeted by 42.09% to $124.2 million in 2023, then increased by 9.50% to $136.0 million in 2024.